VD3 significantly increased the senescent markers INK4A (p16) and CDKN1A (p21) and promoted the expression of histone demethylase KDM6B glioma cells, while it does not affect vitamin D receptor expression. The gene discussed is KDM6B; the disease is central nervous system cancer.